Dow Down 0.02% Nasdaq Up 0.48%

Alexion Pharmaceuticals, Inc. (ALXN)

-NasdaqGS
193.81 Up 1.04(0.54%) 1:58PM EST - Nasdaq Real Time Price
Prev Close:192.77
Open:193.28
Bid:193.78 x 100
Ask:193.87 x 300
1y Target Est:207.20
Beta:1.4
Earnings Date:Jan 28 - Feb 2 (Est.)
Day's Range:191.62 - 194.05
52wk Range:120.14 - 197.64
Volume:315,531
Avg Vol (3m):1,120,250
Market Cap:38.43B
P/E (ttm):80.62
EPS (ttm):2.40
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ALXN

Comparison

Symbol% ChgMkt Cap
ALXNUp 0.54%38.43B
AMGNUp 1.16%124.84B
BAXDown 0.01%39.26B

Key Statistics

Forward P/E (1 yr):32.74
P/S (ttm):18.41
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :5.20
Quarterly EPS Est (Dec-14) :1.29
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):1.21

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback